News Search

Through a trial offered at Columbia, a patient who is ineligible for existing treatments is the first to receive an experimental gene therapy.

A multi-institutional team of researchers developed a tiny implantable microphone, paving the way for fully internal cochlear implants.

Columbia scientists have found that breast cancer patients who are HIV-positive are 40% more likely to have triple-negative breast cancer—the most aggressive subtype—than patients without HIV.